SSB and cerebral infarction: We further add to the current knowledge by demonstrating that positivity for both Ro/SSA and La/SSB autoantibodies mark the subgroup of patients that carry most of the risk of cerebral infarction and VTE, highlighting the importance of taking patient subgroups into account for correctly defining comorbidity risks.